At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
A new study from researchers at University Health Network recommends that all patients with psoriatic arthritis (PsA) be screened for inflammation in their back joints, regardless of whether or not they have back pain.
PsA typically occurs in people with a skin condition known as psoriasis. PsA is characterized by inflammation and pain primarily in the joints of the hands, feet, knees, ankles, wrists, elbows or hips. If left untreated, the disease can lead to irreversible joint damage and disability.
In some patients, PsA can also cause inflammation and pain in the joints of the back, which is referred to as axial arthritis. When axial arthritis occurs in patients, it can signal the presence of more severe forms of PsA — forms that could benefit from treatment with more potent medications.
"Despite its importance, accurately detecting axial arthritis in patients with psoriatic arthritis is difficult," says
Dr. Vinod Chandran, an Affiliate Scientist at the Krembil Research Institute.
"There is no widely accepted definition or test for axial disease in psoriatic arthritis. Instead, when chronic back pain is identified, a rheumatologist will rely on his or her professional judgement to predict whether it is caused by axial arthritis or by other factors, such age, excess weight or osteoarthritis."
In the new study, Dr. Chandran evaluated the accuracy of rheumatologists' prediction in diagnosing axial arthritis in PsA patients.
He enrolled 171 PsA patients with or without back pain into his study. A rheumatologist judged whether or not a patient's back pain was caused by PsA after considering the patient's history and physical examination. Additionally, each patient received a back X-ray to detect inflammation in their back joints.
By comparing results of the X-rays to the predictions made by rheumatologists, Dr. Chandran found that rheumatologists are not very good at detecting axial arthritis in PsA patients. Moreover, he showed that more than 30 per cent of PsA patients with axial arthritis detected by the X-ray images experienced no back pain at all.
"Our findings suggest that rheumatologists should consider conducting back X-rays or MRI in all patients with PsA regardless of the presence or the nature of their back pain," he says. "To date, imaging appears to be the best way to detect axial involvement.
"This approach would also enable rheumatologists to better identify patients with potentially severe PsA early so that their treatments could be better optimized to slow joint damage."
This study was supported by the Krembil Foundation and the Toronto General & Western Hospital Foundation.